If necessary, include additional symptom codes such as R11.2 (nausea) or R10.9 (abdominal pain) for further clarity
L.SeidelA.JacobJ.DoehmerJ.MorrowC
Developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) has been a surprisingly challenging task
However, the clinical efficacy of antioxidants remains controversial, mainly due to nonspecific mechanisms of action, insufficient target specificity, poor in vivo stability, and limited blood-brain barrier permeability (Ashok et al., 2022
Aims: We explored changes in body weight, cardiometabolic and endocrine parameters in obese women with PCOS who continued treatment with metformin 2 years after discontinuation of short-term intervention with semaglutide
14.4.2 Age Restrictions and Clinical Guidelines Adherence to regulatory guidelines is essential